original ) (raw )Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group
Ana-maria Orbai
The Journal of rheumatology, 2017
View PDFchevron_right
Review of the Psoriatic Arthritis Working Group at OMERACT 12: A Report from the GRAPPA 2014 Annual Meeting
Ana-maria Orbai
The Journal of Rheumatology, 2015
View PDFchevron_right
GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies
vibeke strand
Annals of the rheumatic diseases, 2017
View PDFchevron_right
Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting
Ana-maria Orbai
The Journal of rheumatology. Supplement, 2018
View PDFchevron_right
Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting
vibeke strand
The Journal of rheumatology, 2016
View PDFchevron_right
Development of Composite Measures for Psoriatic Arthritis: A Report from the GRAPPA 2010 Annual Meeting
Oliver Fitzgerald
The Journal of Rheumatology, 2012
View PDFchevron_right
A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative
K. Otsa , M. Wit , A. Balanescu
Annals of the Rheumatic Diseases, 2014
View PDFchevron_right
Development of a Disease Activity and Responder Index for Psoriatic Arthritis -- Report of the Psoriatic Arthritis Module at OMERACT 11
Oliver Fitzgerald
The Journal of Rheumatology, 2014
View PDFchevron_right
Development of a Disease Severity and Responder Index for Psoriatic Arthritis (PsA) -- Report of the OMERACT 10 PsA Special Interest Group
vibeke strand
The Journal of Rheumatology, 2011
View PDFchevron_right
Composite Measures in Psoriatic Arthritis: A Report from the GRAPPA 2009 Annual Meeting
vibeke strand
The Journal of Rheumatology, 2011
View PDFchevron_right
PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials
Oliver Fitzgerald
The Journal of Rheumatology
View PDFchevron_right
Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity: OMERACT 2018 Psoriatic Arthritis workshop report
Ana-maria Orbai
The Journal of Rheumatology, 2019
View PDFchevron_right
Psoriatic Arthritis Impact of Disease (PsAID) questionnaire: closer to the all-in-one tool?
Rubén Queiro
Rheumatology
View PDFchevron_right
Systematic literature review of domains assessed in psoriatic arthritis to inform the update of the psoriatic arthritis core domain set
vibeke strand
RMD Open, 2016
View PDFchevron_right
Outcome measures in psoriatic arthritis
vibeke strand
The Journal of rheumatology, 2007
View PDFchevron_right
Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014
vibeke strand
The Journal of rheumatology, 2015
View PDFchevron_right
Consensus on a core set of domains for psoriatic arthritis
vibeke strand
The Journal of rheumatology, 2007
View PDFchevron_right
Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire
Rubén Queiro
Health and Quality of Life Outcomes, 2020
View PDFchevron_right
A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative
Ana-maria Orbai
Seminars in Arthritis and Rheumatism, 2018
View PDFchevron_right
Validation and clinical interpretability of PsAID - psoriatic arthritis impact of disease
Cristiano Campanholo
Advances in Rheumatology
View PDFchevron_right
Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice
Charlotte Cavill
Annals of the rheumatic diseases, 2017
View PDFchevron_right
Critical importance of patient-reported outcomes for a comprehensive assessment of psoriatic arthritis patients
Marika Lo Monaco
Frontiers in Medicine, 2024
View PDFchevron_right
Outcome measures used in psoriatic arthritis registries and cohorts: A systematic literature review of 27 registries or 16,183 patients
Krystel Aouad
Seminars in Arthritis and Rheumatism, 2021
View PDFchevron_right
The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set
Ana-maria Orbai
The Journal of Rheumatology, 2019
View PDFchevron_right
Comorbidities, pain and fatigue in psoriatic arthritis, psoriasis and healthy controls: a clinical cohort study
Kirstine Amris
Rheumatology, 2020
View PDFchevron_right
Psoriatic arthritis impact of disease questionnaire: validity, reliability and its clinical potential
Rossana Scrivo
Rheumatology International, 2020
View PDFchevron_right
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study
Raffaele Scarpa
The Journal of Rheumatology, 2011
View PDFchevron_right
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)
Jaap Fransen
Annals of the Rheumatic Diseases, 2013
View PDFchevron_right